News Analysis

» genetics, synthetic biology and CRISPR/Cas

Most Recent

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: RNAi’s Future in Drug-Target Screening

RNAi’s Future in Drug-Target Screening

By | April 17, 2017

A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

0 Comments

image: With CRISPR, Modeling Disease in Mini Organs

With CRISPR, Modeling Disease in Mini Organs

By | May 6, 2016

Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.

0 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Credit for CRISPR: A Conversation with George Church

Credit for CRISPR: A Conversation with George Church

By | December 29, 2015

The media frenzy over the gene-editing technique highlights shortcomings in how journalists and award committees portray contributions to scientific discoveries.

9 Comments

image: Year in Review: CRISPR Blossoms

Year in Review: CRISPR Blossoms

By | December 16, 2015

As researchers work to improve the precision gene-editing technology, the community discusses the best way to use it.

0 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

7 Comments

image: Recoding Life

Recoding Life

By | January 2, 2014

Rewriting the genetic code can lead to a better understanding of how living cells work, and spawn new biotechnological applications.

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech